Shingrix Vaccination
Shingrix Vaccination

The FDA recently approved the use of Shingrix – a new vaccine developed to prevent Shingles in adults ages 50 and older.  Shingles is a painful itchy rash that develops on one side of the body that can last for two to four weeks. One in three Americans will develop shingles in their lifetime according to the US Centers for Disease Control and Prevention. The Advisory Committee on Immunization Practices, which advises the CDC on vaccine usage, is recommending all adults ages 50 and older, and those previously vaccinated with Zostavax, receive the new vaccine.

For more information on the shingles vaccine visit the US Centers for Disease Control and Prevention website at www.cdc.gov or make a note to discuss with your physician at your next visit.